Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing. The investment was led by 5AM Ventures and Telegraph Hill Partners, with additional participants that include the Rising Tide Fund and other individual investors.
Group NanoXplore Inc., a Montreal-based company specialising in the production and application of graphene and its derivative materials, is pleased to announce that it has participated in the successful financing of two innovative graphene applications companies: NanoPhyll, a company dedicated to improving efficiencies in the photocatalytic and photovoltaic markets through the application of customized graphene; Two Carbon, a materials technology company designing next-generation, high performance outdoor products using graphene as a fundamental building block.
SUSS MicroTec, a leading supplier of equipment and process solutions for the semiconductor industry and related markets, has received an order for multiple SUSS MicroTec Photonic Systems lithography tools in Q3 2015 from a leading semiconductor manufacturer. The strategically important order includes multiple DSC300 Gen2 projection scanners, which are produced at the company’s facility in Corona, USA. The order volume is in the high single-digit million Euro range.
Of late demand for innovative carbon nanotubes in industries is increasing. Carbon nanotubes are used in electronics, transportation sector, fuel cells, and healthcare. At present the carbon nanotubes account for about 28% market share of the total nanomaterial market. The market of the carbon nanotubes is expected to grow at a compound annual growth rate of 16% in the next 3-4 years. The global production of carbon nanotubes in 2014 was around 7000 million tonnes.
Once again, Binghamton University and private industry are teaming up to bring research conducted on campus to the commercial market.
Global demand for nanomaterial in 2014 was $3.4 Billion. Health Care and electronics are the key markets for the nanomaterials. At present of the electronics sector constitutes of 36% and healthcare consists of 35% of the total nanomaterial demand.
Xcelience and Powdersize announced today the addition of the Netzsch Delta Vita media mills, a nanoparticle milling solution, to their arsenal of capabilities. For the first time, one CDMO can provide solutions for a full range of particle size reduction solutions, from milling and micronization through cGMP manufacturing and global clinical supplies packaging and logistics.
The nano cellulose market is estimated around $ 250 million in 2014, with the high share held by North America and Europe together. The global nano cellulose market by value is projected to grow at a CAGR of approximately 19% from 2014 to 2019. The high growth is forecasted to be in the North America and Europe due to rising advancements in the end industries such as paper and paper board, composites & packaging, biomedicine in the region. Europe is estimated to have the second highest growth from 2014 to 2019.
Global Nanomaterials market is currently valued at $3.4 billion in 2014 and is expected to reach $11.8 billion by 2020 showing a compound annual growth rate of 23.1%. North America will remain the market leading region for several years as it has significant ongoing R & D activities in nanomaterials.
leon-nanodrugs GmbH today announced the appointment of industry veteran Theron (Ted) Odlaug, Ph.D. as the CEO for the leon-nanodrugs GmbH in Munich, Germany, and of its newly formed U.S. subsidiary leon-nanodrugs Inc., with offices in New York City and Chicago, Illinois. Recently, leon-nanodrugs successfully completed a Series A Financing round and announced using the proceeds to expand its profitable service business and to enter into high margin service and co-development deals with pharmaceutical partners.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.